Literature DB >> 22981550

Type 2 diabetes mellitus and risk of incident atrial fibrillation in women.

Tobias Schoen1, Aruna D Pradhan, Christine M Albert, David Conen.   

Abstract

OBJECTIVES: The purpose of this study was to assess whether changes of major atrial fibrillation (AF) risk factors and/or intercurrent cardiovascular events could explain the relationship between type 2 diabetes mellitus (T2D) and incident AF.
BACKGROUND: Previous studies found an increased risk of incident AF among individuals with T2D, but few, if any, of these studies took into account changes of AF risk factors over time.
METHODS: A total of 34,720 female health professionals who participated in the Women's Health Study, and who were free of cardiovascular disease and AF at baseline were followed for a median of 16.4 years. Cox proportional-hazards models were constructed to assess the relationship between T2D and incident AF, using either information at baseline or time-varying covariates for both T2D and potential confounders.
RESULTS: At baseline, 937 (2.7 %) women had T2D. Compared with women without T2D, women with T2D had an age-adjusted hazard ratio (HR) for new-onset AF of 1.95 (95% confidence interval [CI]: 1.49 to 2.56; p<0.0001). In multivariable analyses adjusting for baseline confounders, this HR was substantially attenuated, but baseline T2D remained a significant predictor of incident AF (HR: 1.37, 95% CI: 1.03 to 1.83; p=0.03). In time-updated models that adjusted for changes in AF risk factors and intercurrent cardiovascular events, the HR for T2D was attenuated further and became nonsignificant (HR: 1.14; 95% CI: 0.93 to 1.40; p=0.20).
CONCLUSIONS: Although this study confirms a significant relationship between baseline T2D and incident AF, our data suggest that the increased risk associated with T2D is mainly mediated by changes of other AF risk factors.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981550      PMCID: PMC4277997          DOI: 10.1016/j.jacc.2012.06.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

1.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.

Authors:  Aruna D Pradhan; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

2.  Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; Aruna D Pradhan; Julie E Buring; Simin Liu
Journal:  Diabetes Care       Date:  2007-09       Impact factor: 19.112

3.  Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Authors:  I-Min Lee; Nancy R Cook; J Michael Gaziano; David Gordon; Paul M Ridker; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

4.  Thyroid status, cardiovascular risk, and mortality in older adults.

Authors:  Anne R Cappola; Linda P Fried; Alice M Arnold; Mark D Danese; Lewis H Kuller; Gregory L Burke; Russell P Tracy; Paul W Ladenson
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

5.  Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Naohito Tanabe; Toru Watanabe; Dawood Darbar; Dan M Roden; Shigeru Sasaki; Yoshifusa Aizawa
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

6.  Alcohol consumption and risk of incident atrial fibrillation in women.

Authors:  David Conen; Usha B Tedrow; Nancy R Cook; M V Moorthy; Julie E Buring; Christine M Albert
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

7.  Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study.

Authors:  David Conen; Paul M Ridker; Samia Mora; Julie E Buring; Robert J Glynn
Journal:  Eur Heart J       Date:  2007-10-09       Impact factor: 29.983

Review 8.  Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review.

Authors:  W S Leslie; C R Hankey; M E J Lean
Journal:  QJM       Date:  2007-06-12

9.  Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.

Authors:  David Conen; Usha B Tedrow; Bruce A Koplan; Robert J Glynn; Julie E Buring; Christine M Albert
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

10.  A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.

Authors:  Aruna D Pradhan; Nancy R Cook; Joann E Manson; Paul M Ridker; Julie E Buring
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

View more
  30 in total

1.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Authors:  Omid Fatemi; Eugene Yuriditsky; Costas Tsioufis; Demetrios Tsachris; Timothy Morgan; Jan Basile; Thomas Bigger; William Cushman; David Goff; Elsayed Z Soliman; Abraham Thomas; Vasilios Papademetriou
Journal:  Am J Cardiol       Date:  2014-07-30       Impact factor: 2.778

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 3.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

4.  Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.

Authors:  Neal A Chatterjee; Claudia U Chae; Eunjung Kim; M Vinayaga Moorthy; David Conen; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Christine M Albert
Journal:  JACC Heart Fail       Date:  2017-06-14       Impact factor: 12.035

5.  Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

Authors:  Björn Zethelius; Soffia Gudbjörnsdottir; Björn Eliasson; Katarina Eeg-Olofsson; Ann-Marie Svensson; Jan Cederholm
Journal:  Diabetologia       Date:  2015-06-19       Impact factor: 10.122

6.  Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.

Authors:  Roopinder K Sandhu; David Conen; Usha B Tedrow; Kathryn C Fitzgerald; Aruna D Pradhan; Paul M Ridker; Robert J Glynn; Christine M Albert
Journal:  J Am Heart Assoc       Date:  2014-05-01       Impact factor: 5.501

7.  Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.

Authors:  Matthias Bossard; Rahel Kreuzmann; Thomas Hochgruber; Philipp Krisai; Andreas J Zimmermann; Stefanie Aeschbacher; Katrin Pumpol; Arnheid Kessel-Schaefer; Frank-Peter Stephan; Nadja Handschin; Christian Sticherling; Stefan Osswald; Beat A Kaufmann; Guillaume Paré; Michael Kühne; David Conen
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

8.  Is SYNTAX Score Predictive of Atrial Fibrillation after On-Pump Coronary Artery Bypass Graft Surgery?

Authors:  Levent Cerit; Hamza Duygu; Kamil Gulsen; Hatice S Kemal; Barcın Ozcem; Ozlem Balcioglu; Aziz Gunsel; Ozgur Tosun; Volkan Emren
Journal:  Korean Circ J       Date:  2016-11-01       Impact factor: 3.243

9.  Diabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese population.

Authors:  Guozhe Sun; Mingfeng Ma; Ning Ye; Jun Wang; Yintao Chen; Dongxue Dai; Yingxian Sun
Journal:  J Diabetes Investig       Date:  2016-02-21       Impact factor: 4.232

10.  Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.

Authors:  Jakub Gumprecht; Gregory Y H Lip; Adam Sokal; Beata Średniawa; Katarzyna Mitręga; Jakub Stokwiszewski; Łukasz Wierucki; Aleksandra Rajca; Marcin Rutkowski; Tomasz Zdrojewski; Tomasz Grodzicki; Jarosław Kaźmierczak; Grzegorz Opolski; Zbigniew Kalarus
Journal:  Cardiovasc Diabetol       Date:  2021-06-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.